New lipids for RNA delivery
Learn more about how the mRNA and lipid nanoparticles team is developing novel lipids to create cost-effective RNA delivery systems.
The problem
Current ionisable lipid nanoparticle technologies for delivering RNA are limited by high costs and licensing challenges, hindering the development of mRNA-based vaccines and therapeutics.
Our solution
We will design, synthesize, and test novel ionisable lipids to create new formulations to deliver RNA therapeutics for a range of different applications.
The impact
Our project aims to make RNA delivery technology more cost-effective and versatile, enabling the development of more affordable and accessible RNA-based vaccines and therapeutics, which could have a significant impact on global health.
This project is funded by RNA Platform Fast Start.
Research team
mRNA and lipid nanoparticles team
Design and synthesis of vaccine adjuvants and ionisable lipids use in vaccines and immunotherapeutics.
Publications
No result found